|Series E, 5/11 ||$25.5M|
|Series E, 6/12 ||$12M|
Arstasis, Inc., headquartered in Redwood City, California, is a medical device manufacturer dedicated to bringing innovative access devices to cardiologists, interventional radiologists, their staffs, and patients. The company’s lead product, the AXERA Access Device, was launched in the U.S. in April 2011. The device is used in the Arstaotomyâ„¢ procedure, a new way to gain access to the femoral artery that some physicians believe results in a more pleasant and efficient cath lab and post-procedure experience for clinician and patient alike.